ATE307594T1 - Anaesthetische zusammensetzungen enthaltend alfaxalon - Google Patents

Anaesthetische zusammensetzungen enthaltend alfaxalon

Info

Publication number
ATE307594T1
ATE307594T1 AT01913388T AT01913388T ATE307594T1 AT E307594 T1 ATE307594 T1 AT E307594T1 AT 01913388 T AT01913388 T AT 01913388T AT 01913388 T AT01913388 T AT 01913388T AT E307594 T1 ATE307594 T1 AT E307594T1
Authority
AT
Austria
Prior art keywords
alfaxalone
compositions containing
anaesthetic compositions
anaesthetic
solution
Prior art date
Application number
AT01913388T
Other languages
English (en)
Inventor
Peter John Kieran
Kai Kin Lau
Barry Edward Patten
Original Assignee
Jurox Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jurox Pty Ltd filed Critical Jurox Pty Ltd
Application granted granted Critical
Publication of ATE307594T1 publication Critical patent/ATE307594T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Nanotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Dermatology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
AT01913388T 2000-03-20 2001-03-20 Anaesthetische zusammensetzungen enthaltend alfaxalon ATE307594T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPQ6339A AUPQ633900A0 (en) 2000-03-20 2000-03-20 Anaesthetic composition
PCT/AU2001/000307 WO2001070234A1 (en) 2000-03-20 2001-03-20 Anaesthetic composition

Publications (1)

Publication Number Publication Date
ATE307594T1 true ATE307594T1 (de) 2005-11-15

Family

ID=3820436

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01913388T ATE307594T1 (de) 2000-03-20 2001-03-20 Anaesthetische zusammensetzungen enthaltend alfaxalon

Country Status (8)

Country Link
US (4) US7897586B2 (de)
EP (1) EP1265618B1 (de)
JP (1) JP4886145B2 (de)
AT (1) ATE307594T1 (de)
AU (1) AUPQ633900A0 (de)
CA (1) CA2400133C (de)
DE (1) DE60114384T2 (de)
WO (1) WO2001070234A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070166187A1 (en) * 2006-01-18 2007-07-19 Song Jing F Stabilization of paricalcitol using chlorobutyl or chlorinated butyl stoppers
RU2574022C2 (ru) * 2010-01-21 2016-01-27 Дробридж Фармасьютикалз Пти Лтд. Анестезирующий состав
AU2013200895C1 (en) * 2010-01-21 2014-02-06 Drawbridge Pharmaceuticals Pty Ltd Anaesthetic formulation
JP5819005B2 (ja) 2011-11-29 2015-11-18 ジュロックス プロプライエタリー リミテッド 薬学的組成物
ES2576077B1 (es) * 2016-03-04 2017-03-24 Universidad Politécnica De Cartagena Solución anestesiante y su método de aplicación para el anestesiado, aturdido y sacrificio de peces

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4727064A (en) * 1984-04-25 1988-02-23 The United States Of America As Represented By The Department Of Health And Human Services Pharmaceutical preparations containing cyclodextrin derivatives
ES2058503T5 (es) * 1988-03-29 1999-04-16 Univ Florida Formulaciones farmaceuticas para uso parenteral.
ES2062359T3 (es) * 1989-05-24 1994-12-16 Innovet Inc Un procedimiento de preparacion de una composicion anestesica o hipnotica esteroidal hipoalergenica.
WO1993017711A1 (en) 1992-03-11 1993-09-16 Australian Commercial Research & Development Limited New cyclodextrins and new formulated drugs
US5324718A (en) * 1992-07-14 1994-06-28 Thorsteinn Loftsson Cyclodextrin/drug complexation
US5472954A (en) * 1992-07-14 1995-12-05 Cyclops H.F. Cyclodextrin complexation
DE4242919A1 (de) 1992-12-18 1994-06-23 Boehringer Mannheim Gmbh Verfahren zur Herstellung von lagerstabilen wässrigen pharmazeutischen Zubereitungen von G-CSF
FR2733423B1 (fr) * 1995-04-26 1997-06-20 Virbac Lab Compositions pulverulentes et solubles dans l'eau et leurs applications
TW385248B (en) 1995-10-27 2000-03-21 Merck & Co Inc Pharmaceutical compositions for intravenous administration for inhibiting platelet aggregation
DE69924232D1 (de) 1998-01-09 2005-04-21 Novo Nordisk As Stabilisierte insulin-zubereitungen
US6123123A (en) * 1999-08-03 2000-09-26 M. Carder Industries, Incorporated Non-stretch breakaway hose particularly for fuel dispenser

Also Published As

Publication number Publication date
US7897586B2 (en) 2011-03-01
US20120316134A1 (en) 2012-12-13
EP1265618B1 (de) 2005-10-26
DE60114384T2 (de) 2006-07-06
JP2003527431A (ja) 2003-09-16
CA2400133A1 (en) 2001-09-27
AUPQ633900A0 (en) 2000-04-15
US20030064961A1 (en) 2003-04-03
US9427443B2 (en) 2016-08-30
EP1265618A1 (de) 2002-12-18
EP1265618A4 (de) 2004-05-19
DE60114384D1 (de) 2005-12-01
JP4886145B2 (ja) 2012-02-29
WO2001070234A1 (en) 2001-09-27
US20140323454A1 (en) 2014-10-30
CA2400133C (en) 2008-05-06
US20110152216A1 (en) 2011-06-23

Similar Documents

Publication Publication Date Title
ATE324122T1 (de) Verwendung einer zusammensetzung die einen chelatbildner und eine antimikrobielle verbindung enthaltet zur behandlung von biofilmen
TR200302105T4 (tr) Siklosporin, hiyalüronik asit ve polisorbat içeren göz formülasyonları.
ATE421248T1 (de) Antiseptische zusammensetzungen und verfahren
PT1117440E (pt) Composicoes farmaceuticas que contem paclitaxel
IS7214A (is) Samsetningar sem samanstanda af sefalósporin efnasambandi og notkun þeirra við meðhöndlun á bakteríusýkingum í köttum og hundum
DK1100344T3 (da) Chitosanholdige flydende præparater og fremgangsmåder til deres fremstilling og anvendelse
FI963232A0 (fi) Antimikrobisena aineena käytettävä hapotettu nitriitti
HK1058763A1 (en) Compositions and methods to improve the oral absorption of antimicrobial agents
BR0116691A (pt) Produto antitranspirante, métodos cosméticos para atingir antitranspiração e/ou benefìcio desodorante e método para a fabricação de uma composição antitranspirante
BR0113751A (pt) Composições cosméticas e farmacêuticas e seus empregos
MXPA04006210A (es) Composiciones acuosas que contienen metronidazole.
CY1110061T1 (el) Συνθεσεις περιλαμβανοντας ενωσεις μοδαφινιλης
UA97346C2 (ru) Стабильная эмульсионная композиция
ATE282317T1 (de) Antimikrobielle zusammensetzung zur behandlung von rindermastitis
GT199900211A (es) Formulaciones plaguicidas que contienen tensoactivos de amina alcoxilada neutralizados con ester de hemisulfatodetriestirilfenol alcoxilado.
DK1104289T3 (da) Hidtil ukendte orale formuleringer for 5-HT4-agonister eller -antagonister
BR0313257A (pt) Composição pesticida granulada
BR9911236A (pt) Solução e método de limpeza
ATE307594T1 (de) Anaesthetische zusammensetzungen enthaltend alfaxalon
HRP20030433B1 (en) Dermatological formulations containing clindamycin and a zinc-salt
ATE274570T1 (de) Pumpfähige wässrige zusammensetzungen mit hohem feststoffgehalt und hohem anteil an monoalkylphosphatestersalz
DK0921793T3 (da) Faste, ikke-henflydende formuleringer af natriumvalproat
AR245591A1 (es) Una composicion oral estable, con propiedades antiplaca y antigingivales mejoradas.
UY27373A1 (es) Formulaciones de interferón beta-humano
ME00568B (me) Vodena farmaceutska kompozicija koja sadrži ciklesonid

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties